Obesity-associated endometrial and cervical cancers

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 1, 2013, Pages 109-118

  Gu, Wenyi ^a   Chen, Chen ^a   Zhao, Kong Nan ^b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cervical cancer; Endometrial cancer; Obesity

Indexed keywords

CYTOKINE; HORMONE;

CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; DELAYED DIAGNOSIS; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; HUMAN; LIFESTYLE; OBESITY; POSTMENOPAUSE; REVIEW; UTERINE CERVIX CANCER; WART VIRUS; ALPHAPAPILLOMAVIRUS; BIOLOGICAL MODEL; FEMALE; FEMALE GENITAL TRACT TUMOR; PATHOPHYSIOLOGY; RISK FACTOR; VIROLOGY;

ALPHAPAPILLOMAVIRUS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LIFE STYLE; MODELS, BIOLOGICAL; OBESITY; RISK FACTORS;

MLCS; MLOWN;

EID: 84878503263     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e600     Document Type: Review

References (101)

1. B Rokholm, JL Baker, TI Sorensen. The levelling off of the obesity epidemic since the year 1999 - a review of evidence and perspectives. Obes Rev. 11(12), 835-46 (2010)
2. H Skouteris, L Hartley-Clark, M McCabe, J Milgrom, B Kent, SJ Herring, J Gale. Preventing excessive gestational weight gain: a systematic review of interventions. Obes Rev. 11(11), 757-68 (2010)
3. N Delzenne, J Blundell, F Brouns, K Cunningham, K De Graaf, A Erkner, A Lluch, M Mars, HP Peters, M Westerterp-Plantenga. Gastrointestinal targets of appetite regulation in humans. Obes Rev. 11(3), 234-50 (2010)
4. JC Barte, NC ter Bogt, RP Bogers, PJ Teixeira, B Blissmer, TA Mori, WJ Bemelmans. Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review. Obes Rev. 11, 899-906 (2010)
5. J Blundell, C de Graaf, T Hulshof, S Jebb, B Livingstone, A Lluch, D Mela, S Salah, E Schuring, H van der Knaap, M Westerterp. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 11, 251-70 (2010)
6. EE Calle, R Kaaks. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4, 579-91 (2004). (Pubitemid 39025053)
7. AG Renehan, M Tyson, M Egger, RF Heller, M Zwahlen. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569-78 (2008) (Pubitemid 351232031)
8. JA Thomas, SJ Freedland, Obesity and prostate cancer: collateral damage in the battle of the bulge. Front Biosci (Schol Ed) 3, 594-605 (2011)
9. T Mijovic, J How, RJ Payne. Obesity and thyroid cancer. Front Biosci (Schol Ed) 3, 555-64 (2011)
10. XF Huang, JZ Chen. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev. 10, 610-6 (2009)
11. G Paz-Filho, EL Lim, ML Wong, J Licinio. Associations between adipokines and obesity-related cancer. Front Biosci. 16, 1634-50 (2011)
12. P Kant, MA Hull. Excess body weight and obesity - the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol. 8, 224-38 (2011)
13. SC Modesitt, JR van Nagell, The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 60, 683-92 (2005) (Pubitemid 41368535)
14. A Papadia, N Ragni, EM Salom, The impact of obesity on surgery in gynecological oncology: a review. Int J Gynecol Cancer 16, 944-52 (2006)
15. T Aldrich, B Hackley, The impact of obesity on gynecologic cancer screening: an integrative literature review. J Midwifery Womens Health 55, 344-56 (2010)
16. IE Martinek, K Haldar, R Tozzi, Laparoscopic surgery for gynaecological cancers in obese women. Maturitas 65, 320-4 (2010)
17. T Kulie, A Slattengren, J Redmer, H Counts, A Eglash, S Schrager. Obesity and women's health: an evidencebased review. J Am Board Fam Med. 24, 75-85 (2011)
18. E Duarte-Franco, EL Franco, Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers. BMC Womens Health. 4 Suppl 1, S14 (2004).
19. WT Creasman, F Odicino, P Maisonneuve, MA Quinn, U Beller, JL Benedet, AP Heintz, HY Ngan, S Pecorelli. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 95 Suppl 1, S105-43 (2006)
20. C Grundker, AR Gunthert, G Emons, Hormonal heterogeneity of endometrial cancer. Adv Exp Med Biol. 630, 166-88 (2008)
21. AN Fader, LN Arriba, HE Frasure, and VE von Gruenigen. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 114, 121-7 (2009)
22. MH Tao, JL Freudenheim, DNA methylation in endometrial cancer. Epigenetics 5, 491-8 (2008)
23. GH Twombly, S Scheiner, M Levitz, Endometrial cancer, obesity, and estrogenic excretion in women. Am J Obstet Gynecol. 82, 424-7 (1961)
24. PC MacDonald, CD Edman, DL Hemsell, JC Porter, PK Siiteri. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol. 130, 448-55 (1978) (Pubitemid 8291952)
25. I Fujimoto, T Hamada, K Hasumi, K Masubuchi, G Sakamoto, H Sugano. Epidemiological survey on the relationship between obesity and endometrial cancer. Gan No Rinsho. 32, 1561-6 (1986)
26. H Austin, JM Austin, EE Partridge, KD Hatch, HM Shingleton. Endometrial cancer, obesity, and body fat distribution. Cancer Res. 51, 568-72 (1991)
27. ML McCullough, AV Patel, R Patel, C Rodriguez, HS Feigelson, EV Bandera, T Gansler, MJ Thun, EE Calle. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev. 17, 73-9 (2008) (Pubitemid 351196275)
28. K Lindemann, LJ Vatten, M Ellstrom-Engh, A Eskild. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 98, 1582-5 (2008) (Pubitemid 351652323)
29. SY Tong, LJ Vatten, M Ellstrom-Engh, A Eskild. The effects of obesity and HER-2 polymorphisms as risk factors for endometrial cancer in Korean women. BJOG. 116, 1046-52 (2009)
30. DS Heller, C Mosquera, LT Goldsmith, B Cracchiolo. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding. J Reprod Med. 56, 110-2 (2011)
31. E Salazar-Martinez, EC Lazcano-Ponce, GG Lira-Lira, P Escudero-De los Rios, J Salmeron-Castro, F Larrea, M Hernandez-Avila. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11, 707-11 (2000)
32. B Anderson, JP Connor, JI Andrews, CS Davis, RE Buller, JI Sorosky, JA Benda. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol. 174, 1171-8 (1996)
33. VM Chia, PA Newcomb, A Trentham-Dietz, JM Hampton. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer. 2007. 17, 441-6 (2007) (Pubitemid 46426761)
34. K Basen-Engquist, S Scruggs, A Jhingran, DC Bodurka, K Lu, L Ramondetta, D Hughes, C Carmack Taylor. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol. 200, e1-8 (2009)
35. KW Reeves, GC Carter, RJ Rodabough, D Lane, SG McNeeley, ML Stefanick, ED Paskett. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol. 121, 376-82 (2011)
36. R Kaaks, A Lukanova, MS Kurzer. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 11, 1531-43 (2002) (Pubitemid 36020003)
37. M Mori, S Sagae. Recent progress in epidemiologic research of uterine cancer. Gan To Kagaku Ryoho. 28, 174-8 (2001)
38. C La Vecchia, S Franceschi, G Gallus, A Decarli, E Colombo, A Liberati, G Tognoni. Prognostic features of endometrial cancer in estrogen users and obese women. Am J Obstet Gynecol. 144, 387-90 (1982) (Pubitemid 12033904)
39. N Ashizawa, T Yahata, J Quan, S Adachi, K Yoshihara, K Tanaka. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol. 119, 65-9 (2010)
40. AG Renehan, M Zwahlen, C Minder, ST O'Dwyer, SM Shalet, M Egger. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346-53 (2004) (Pubitemid 38529873)
41. J Chen, A Katsifis, C Hu, XF Huang. Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3K/Akt pathway. Curr Drug Discov Technol. 8, 119-25 (2011)
42. Y Zhang, R Proenca, M Maffei, M Barone, L Leopold, JM Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-32 (1994) (Pubitemid 24365442)
43. A Fukuhara, M Matsuda, M Nishizawa, K Segawa, M Tanaka, K Kishimoto, Y Matsuki, M Murakami, T Ichisaka, H Murakami, E Watanabe, T Takagi, M Akiyoshi, T Ohtsubo, S Kihara, S Yamashita, M Makishima, T Funahashi, S Yamanaka, R Hiramatsu, Y Matsuzawa, I Shimomura. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426-30 (2005) (Pubitemid 40139988)
44. CM Lopez Fontana, ME Maselli Artola, N Di Milta Monaco, GM Recalde Rincon, MC Vanrell Rodriguez, A Uvilla Recupero, D Messina Lombino, RF Perez Elizalde, JD Lopez Laur. Influence of leptin and adiponectin on prostate cancer. Arch Esp Urol. 62, 103-8 (2009)
45. RC van Kruijsdijk, E van der Wall, FL Visseren. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18, 2569-78 (2009)
46. G Paz-Filho, ML Wong, Licinio. Ten years of leptin replacement therapy. Obes Rev. 12, e315-23 (2011)
47. JM Howard, GP Pidgeon, JV Reynolds. Leptin and gastro-intestinal malignancies. Obes Rev. 11, 863-74 (2002)
48. E Klimcakova, M Kovacikova, V Stich, D Langin. Adipokines and dietary interventions in human obesity. Obes Rev 11, 446-56 (2010)
49. Margetic, S., C. Gazzola, G. G. Pegg, and R. A. Hill. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord. 26, 1407-33 (2002) (Pubitemid 36007818)
50. L Tessitore, B Vizio, D Pesola, F Cecchini, A Mussa, JM Argiles, C Benedetto. Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol. 24, 1529-35 (2004)
51. C Garofalo, E Surmacz. Leptin and cancer. J Cell Physiol. 207, 12-22 (2006)
52. GB Tucker. Bariatric Times 8, 16-19 (2011)
53. E Petridou, C Mantzoros, N Dessypris, P Koukoulomatis, C Addy, Z Voulgaris, G Chrousos, D Trichopoulos. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab. 88, 993-7 (2003) (Pubitemid 36337745)
54. Hoffstedt, J., E. Arvidsson, E. Sjolin, K. Wahlen, and P. Arner. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab. 89, 1391-6 (2004) (Pubitemid 38368442)
55. RS Ahima, JS Flier, Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 11, 327-32 (2000).
56. N Tawadros, LA Salamonsen, E Dimitriadis, C Chen. Facilitation of decidualization by locally produced ghrelin in the human endometrium. Mol Hum Reprod 13, 483-9 (2007) (Pubitemid 47062887)
57. JN Fung, I Seim, D Wang, A Obermair, LK Chopin, C Chen. Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm Cancer 1, 245-55 (2010)
58. BE Wisse. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 15, 2792-800 (2004). (Pubitemid 41103388)
59. HS Park, JY Park, R Yu, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNFalpha and IL-6. Diabetes Res Clin Pract. 69, 29-35 (2005) (Pubitemid 40813409)
60. M Galgani, G Matarese, Editorial: acute inflammation in obesity: IL-17A in the middle of the battle. J Leukoc Biol. 87, 17-8 (2010)
61. Sumarac-Dumanovic, M., D. Stevanovic, A. Ljubic, J. Jorga, M. Simic, D. Stamenkovic-Pejkovic, V. Starcevic, V. Trajkovic, and D. Micic. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 33, 151-6 (2006)
62. J Chen. The IL-23/IL-17 axis may be important in obesity-associated cancer by way of the activation of multiple signal pathways. Int J Obes (Lond) 34, 1227-8 (2010)
63. T Gislette, J Chen. The possible role of IL-17 in obesity-associated cancer. ScientificWorldJournal 10, 2265-71 (2010)
64. W Wen, Q Cai, YB Xiang, WH Xu, ZX Ruan, J Cheng, W Zheng, XO Shu. The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer 112, 2409-16 (2008)
65. KK Berry, ML Varney, BJ Dave, CD Bucana, IJ Fidler, RK Singh. Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines. Int J Gynecol Cancer 11, 54-60 (2001) (Pubitemid 32216908)
66. J Yap, LA Salamonsen, T Jobling, PK Nicholls, E Dimitriadis. Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma. Reprod Biol Endocrinol. 8. 63 (2010)
67. HH Lin, CJ Liao, YC Lee, KH Hu, HW Meng, and ST Chu. Lipocalin-2-induced cytokine production enhances endometrial carcinoma cell survival and migration. Int J Biol Sci. 7, 74-86 (2011)
68. Gaudet, M. M., H. P. Yang, J. G. Bosquet, C. S. Healey, S. Ahmed, A. M. Dunning, D. F. Easton, A. B. Spurdle, K. Ferguson, T. O'Mara, D. Lambrechts, E. Despierre, I. Vergote, F. Amant, J. V. Lacey, Jr., J. Lissowska, B. Peplonska, L. A. Brinton, S. Chanock, and M. Garcia-Closas. No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 19, 2106-9 (2010)
69. TM Frayling, NJ Timpson, MN Weedon, E Zeggini, RM Freathy, CM Lindgren, JR Perry, KS Elliott, H Lango, NW Rayner, B Shields, LW Harries, JC Barrett, S Ellard, CJ Groves, B Knight, AM Patch, AR Ness, S Ebrahim, DA Lawlor, SM Ring, Y Ben-Shlomo, MR Jarvelin, U Sovio, AJ Bennett, D Melzer, L Ferrucci, RJ Loos, I Barroso, NJ Wareham, F Karpe, KR Owen, LR Cardon, M Walker, GA Hitman, CN Palmer, AS Doney, AD Morris, GD Smith, AT Hattersley, MI McCarthy. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-94 (2007) (Pubitemid 46764279)
70. LJ Scott, KL Mohlke, LL Bonnycastle, CJ Willer, Y Li, WL Duren, MR Erdos, HM Stringham, PS Chines, AU Jackson, L Prokunina-Olsson, CJ Ding, AJ Swift, N Narisu, T Hu, R Pruim, R Xiao, XY Li, KN Conneely, NL Riebow, AG Sprau, M Tong, PP White, KN Hetrick, MW Barnhart, CW Bark, JL Goldstein, L Watkins, F Xiang, J Saramies, TA Buchanan, RM Watanabe, TT Valle, L Kinnunen, GR Abecasis, EW Pugh, KF Doheny, RN Bergman, J Tuomilehto, FS Collins, and M Boehnke. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-5 (2007) (Pubitemid 46871655)
71. G Lurie, MM Gaudet, AB Spurdle, ME Carney, LR Wilkens, HP Yang, NS Weiss, PM Webb, PJ Thompson, K Terada, VW Setiawan, TR Rebbeck, J Prescott, I Orlow, T O'Mara, SH Olson, SA Narod, RK Matsuno, J Lissowska, X Liang, DA Levine, L Le Marchand, LN Kolonel, BE Henderson, M Garcia-Closas, JA Doherty, I De Vivo, C Chen, LA Brinton, MR Akbari, MT Goodman. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One 6, e16756 (2011)
72. P Kastner, A Krust, B Turcotte, U Stropp, L Tora, H Gronemeyer, P Chambon. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9, 1603-14 (1990)
73. I De Vivo, GS Huggins, SE Hankinson, PJ Lescault, M Boezen, GA Colditz, DJ Hunter. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 99, 12263-8 (2002)
74. VW Setiawan, JA Doherty, XO Shu, MR Akbari, C Chen, I De Vivo, A Demichele, M Garcia-Closas, MT Goodman, CA Haiman, SE Hankinson, BE Henderson, PL Horn-Ross, JV Lacey, Jr L Le Marchand, DA Levine, X Liang, J Lissowska, G Lurie, M McGrath, SA Narod, TR Rebbeck, G Ursin, NS Weiss, YB Xiang, HP Yang, W Zheng, SH Olson. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol Biomarkers Prev 18, 242-7 (2009)
75. LM Berstein, EN Imyanitov, AJ Kovalevskij, SJ Maximov, DA Vasilyev, KG Buslov, AP Sokolenko, AG Iyevleva, EV Chekmariova, JH Thijssen. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Cancer Lett. 207, 191-6 (2004) (Pubitemid 38457040)
76. RA Paynter, SE Hankinson, GA Colditz, P Kraft, DJ Hunter, I De Vivo. CYP19 (aromatase) haplotypes and endometrial cancer risk. Int J Cancer 116, 267-74 (2005) (Pubitemid 40967264)
77. MH Tao, Q Cai, ZF Zhang, WH Xu, N Kataoka, W Wen, YB Xiang, W Zheng, XO Shu. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 16, 943-9 (2007) (Pubitemid 46910096)
78. SH Olson, I Orlow, S Bayuga, C Sima, EV Bandera, K Pulick, S Faulkner, D Tommasi, D Egan, P Roy, H Wilcox, A Asya, I Modica, H Asad, R Soslow, AG Zauber. Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control 19, 955-63 (2008)
79. Wee, C. C., E. P. McCarthy, R. B. Davis, and R. S. Phillips. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 132, 697-704 (2000) (Pubitemid 30244168)
80. M Helen, R Psarakis. Diabetes Spectrum 19, 157-62 (2006)
81. S Shimano, M Fukushima, Y Yamakawa, A Nishikawa, F Sato, K Honma, K Kouda, K Fujinaga, M Hashimoto. A case report of Buschke-Lowenstein tumor (giant condyloma) Rinsho Byori 39, 97-101 (1991)
82. B Richter, G Neises, and K Bergerhoff. Human versus animal insulin in people with diabetes mellitus. A systematic review. Endocrinol Metab Clin North Am 31, 723-49 (2002) (Pubitemid 35006618)
83. ON Richter, K Tschubel, J Schmolling, M Kupka, U Ulrich, and E Wardelmann. Immunohistochemical reactivity of myometrial oxytocin receptor in extracorporeally perfused nonpregnant human uteri. Arch Gynecol Obstet 269, 16-24 (2006) (Pubitemid 37408837)
84. K Bobrowska, P Kaminski, A Cyganek, J Jabiry-Zieniewicz, L Bablok, M Durlik, and P Fiedor. Multiple neoplastic lesions of the lower genital tract in a human papilloma virus-infected kidney-pancreas allograft recipient: a case report. Transplant Proc 37, 2093-5 (2005) (Pubitemid 40956382)
85. M Matei, S Olteanu, C Ciolpan, and D Azoicai. Crosssectional epidemiological research on genital and breast cancers in the North-East region of Romania. Rev Med Chir Soc Med Nat Iasi 112, 775-85 (2008)
86. S Hietanen, U Ekblad, TT Pelliniemi, K Syrjanen, H Helenius, S Syrjanen. Type I diabetic pregnancy and subclinical human papillomavirus infection. Clin Infect Dis 24, 153-6 (1997) (Pubitemid 27081536)
87. EM Smith, SR Johnson, D Jiang, S Zaleski, CF Lynch, S Brundage, RD Anderson, LP Turek. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev 15, 397-402 (1991)
88. M Szepietowska, H Slodzinski, M Polz-Dacewicz, J Oleszczuk. Evaluation of frequency human papillomavirus infections during pregnancy. Ginekol Pol 73, 662-5 (2002)
89. G Rieck, A Fiander, The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol 20, 227-51 (2006) (Pubitemid 43380598)
90. R Asgard, E Rytter, S Basu, L Abramsson-Zetterberg, L Moller, B Vessby. High intake of fruit and vegetables is related to low oxidative stress and inflammation in a group of patients with type 2 diabetes. Scand J Food Nutr. 51, 149-158 (2007) (Pubitemid 350249327)
91. PJ Eifel, A Jhingran, DC Bodurka, C Levenback, H Thames. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20, 3651-7 (2002) (Pubitemid 34983225)
92. RS Mitchell, RS Padwal, AW Chuck, SW Klarenbach. Cancer screening among the overweight and obese in Canada. Am J Prev Med 35, 127-32 (2008) (Pubitemid 351915789)
93. W Nelson, RP Moser, A. Gaffey, W Waldron. Adherence to cervical cancer screening guidelines for U. S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS) J Womens Health (Larchmt) 18, 1759-68 (2009)
94. SS Cohen, RT Palmieri, SJ Nyante, DO Koralek, S Kim, P Bradshaw, AF Olshan. Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 112, 1892-904 (2008) (Pubitemid 351574064)
95. CC Wee, RS Phillips, and EP McCarthy. BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States. Obes Res 13, 1275-80 (2005)
96. CC Wee, A Huang, KW Huskey, EP McCarthy. Obesity and the likelihood of sexual behavioral risk factors for HPV and cervical cancer. Obesity (Silver Spring) 16, 2552-5 (2008)
97. CA Moody, LA Laimins. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10, 550-60 (2010)
98. J Bodily, LA Laimins, Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 19, 33-9 (2010)
99. H zur Hausen. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13 (1991)
100. AP Vizcaino, V Moreno, FX Bosch, N Munoz, XM Barros-Dios, DM Parkin. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75, 536-45 (1998) (Pubitemid 28094098)
101. G Leone, A Lanza. Notes on cases of carcinoma of the uterine body observed in the S. Anna Hospital, Turin, between 1954-1969 and the Piedmont and Aosta Valley areas in the period 1965-1969. Arch Sci Med (Torino) 130, 49-96 (1973)